查看購物車
  • English
  • Japanese
  • Korean
體外診斷市場規模及預測（2021-2034）、全球及區域佔有率、趨勢及成長機會分析報告範圍：依產品/服務、技術、應用、最終用戶及地區分類
市場調查報告書
商品編碼
2021162

體外診斷市場規模及預測（2021-2034）、全球及區域佔有率、趨勢及成長機會分析報告範圍：依產品/服務、技術、應用、最終用戶及地區分類

In-Vitro Diagnostic Market Size and Forecast 2021 - 2034, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product & Service, Technology, Application, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 924 Pages | 訂單完成後即時交付

價格
體外診斷市場預計將從2025年的1,120.4億美元成長到2034年的2,187.3億美元。 2026年至2034年間，該市場預計將以7.8%的複合年成長率成長。體外診斷市場成長要素包括：對非侵入性且對患者友善的診斷工具的需求不斷成長；氣喘和慢性阻塞性肺病（COPD）等呼吸系統疾病負擔日益加重；以及家庭監測技術的進步和監管支持。

體外診斷（IVD）是指在人體之外，利用血液、尿液和組織等生物檢體進行的醫學檢測，通常在檢查室、診所或臨床環境中進行。這些檢測對於疾病檢測、健康狀況監測和指南臨床決策至關重要。體外診斷涵蓋多種技術，包括免疫檢測、分子診斷和臨床化學分析儀。它在早期診斷、疾病預防和個人化醫療中發揮關鍵作用。隨著技術的進步，體外診斷正變得越來越快、越來越準確、越來越普及，有助於改善患者預後，並在全球範圍內建立更有效率的醫療保健系統。

北美體外診斷市場分為美國、加拿大和墨西哥三個部分。美國在北美市場佔最大佔有率。根據美國疾病管制與預防中心（CDC）的數據顯示，到2023年，76.4%的美國成年人（約1.94億人）報告患有至少一種慢性疾病，例如心臟病、糖尿病或癌症。各年齡層中多種合併症的普遍存在凸顯了頻繁診斷監測和管理的重要性。 2023年，糖尿病盛行率在各縣之間差異顯著，從4.4%到18.6%不等，反映出代謝性疾病的廣泛流行，需要定期檢查。美國癌症協會估計，到2025年，新增癌症病例將持續居高不下，這將進一步推高對腫瘤診斷的需求。慢性疾病和感染疾病盛行率的這些趨勢正在推動體外診斷技術的廣泛應用，因為常規臨床檢測對於早期發現、治療方案製定和疾病監測至關重要。近期FDA核准的多項產品以及即將於2023年上市的新一代臨床化學和免疫檢測分析儀等產品，提高了檢測能力和速度，增強了診斷的準確性和可及性。分子診斷、就地檢驗和個人化醫療的進步正在擴大體外診斷的應用範圍，滿足公共衛生監測需求，並提升常規臨床決策的品質。

擴大基本診斷的普及範圍和製定國家診斷策略將創造未來的市場機會。

全球體外診斷（IVD）市場最大的機會之一，源自於世界各國政府和衛生組織為提高基本診斷試劑的可及性而進行的協調努力。這些試劑在感染疾病和非傳染性疾病的早期發現、監測和管理中發揮著至關重要的作用。 2023年10月，世界衛生組織（世衛組織）發布了“2023年基本診斷試劑清單（EDL）”，新增了多項關鍵檢測，例如戊型肝炎病毒快速診斷試劑和用於糖尿病管理的個人血糖監測設備。這些更新旨在幫助各國優先考慮高影響力診斷試劑，並改善公共衛生系統的臨床療效。

世界衛生組織的全球診斷優先舉措也與2023年5月世界衛生大會（WHA）第76.5號決議相關。該決議正式呼籲成員國加強其衛生系統各級的診斷能力，這項政策將持續到2024-2025年，並為國家庫存管理和體外診斷產品的優先排序提供實施指導和技術支援。

此外，在印度等國家，根據國家衛生任務實施的免費診斷服務計劃的擴展，預計將在 2024 年 3 月之前逐步改善公共機構中特定強制性檢測的可及性，從而支持對貧血、糖尿病和感染疾病標誌物等疾病進行廣泛的常規篩檢。

這些政策主導的機遇，在官方診斷清單和國家戰略的支持下，正在為臨床環境中廣泛採用體外診斷 (IVD) 創造結構性動力，而此前臨床環境的檢測普及速度一直很慢。

目錄

第1章執行摘要

  • 分析師市場展望
  • 市場吸引力

第2章：體外診斷試劑市場趨勢

  • 價值鏈分析
  • 供應鏈分析
    • 製造商/供應商列表
    • 潛在客戶名單（最多 50 家公司）
  • 波特五力分析
  • PEST分析
  • 主要國家的進出口分析（基於最接近的HS編碼）
    • 主要國家的進出口分析
  • 人工智慧（AI）的影響
  • 產品或技術藍圖
  • 永續發展與ESG趨勢
  • 法律規範

第3章 競爭情勢

  • 主要企業進行標竿分析
  • 市佔率分析（2025 年）－按主要企業分類
  • 市場集中度

第4章：體外診斷市場－主要產業趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來趨勢
  • 促進因素和抑制因素的影響

第5章：體外診斷市場－全球市場分析

  • 體外診斷市場銷售（2021-2034）
  • 體外診斷市場預測與分析

第6章：體外診斷市場收入分析－依產品分類

  • 體外診斷市場產品特定預測與分析
    • 試劑和試劑盒
      • 試劑與試劑盒：體外診斷市場 - 銷售收入，2021-2034 年
    • 裝置
      • 設備：體外診斷市場 - 收入，2021-2034 年
    • 軟體和服務
      • 軟體與服務：體外診斷市場－收入，2021-2034 年

第7章：體外診斷市場收入分析－依技術分類

  • 體外診斷市場預測及技術分析
    • 免疫檢測或免疫化學
      • 免疫檢測或免疫化學：體外診斷市場 - 收入，2021-2034 年
    • 層析法
      • 層析法：體外診斷市場－收入，2021-2034年
    • 細胞分析
      • 細胞分析：體外診斷市場 - 收入，2021-2034 年
    • 蛋白質體學或代謝體學
      • 蛋白質體學或代謝體學：體外診斷市場－收入，2021-2034年
    • 感測器技術
      • 感測器技術：體外診斷市場－收入，2021-2034年
    • 小型化系統
      • 微型化系統：體外診斷市場－收入，2021-2034年
    • 連接複用技術
      • 多重檢測技術：體外診斷市場－收入，2021-2034年
    • 光學檢測
      • 光學檢測：體外診斷市場－收入，2021-2034年
    • 電化學分析
      • 電化學分析：體外診斷市場－收入，2021-2034年
    • 分離技術
      • 分離技術：體外診斷市場－收入，2021-2034年
    • 分子診斷
      • 分子診斷：體外診斷市場 - 收入，2021-2034 年
    • 分析化學
      • 分析化學：體外診斷市場 - 收入，2021-2034 年
    • 分子擴增
      • 分子擴增：體外診斷市場 - 銷售額，2021-2034 年
    • 分子基因體學
      • 分子基因體學：體外診斷市場 - 銷售額，2021-2034 年
    • 高通量分子
      • 高通量分子：體外診斷市場 - 銷售額，2021-2034 年
    • 基因分析
      • 基因分析：體外診斷市場－收入，2021-2034年

第8章 體外診斷市場收入分析－按應用領域分類

  • 按應用領域對體外診斷市場進行預測和分析。
    • 感染疾病
      • 感染疾病：體外診斷市場 - 銷售收入，2021-2034 年
    • 腫瘤學
      • 腫瘤學：體外診斷市場 - 收入，2021-2034 年
    • 循環系統
      • 循環系統醫學：體外診斷市場－收入，2021-2034年
    • 腎臟病學
      • 腎臟病學：體外診斷市場－收入，2021-2034年
    • 糖尿病
      • 糖尿病：體外診斷市場 - 收入，2021-2034 年
    • 遺傳性疾病
      • 遺傳疾病：體外診斷市場 - 銷售額，2021-2034 年
    • 血型鑑定與檢測
      • 血型鑑定與檢測：體外診斷市場－收入，2021-2034年
    • 過敏診斷
      • 過敏診斷：體外診斷市場 - 銷售收入，2021-2034 年
    • 消化系統疾病
      • 消化系統疾病：體外診斷市場 - 銷售收入，2021-2034 年
    • 免疫系統疾病
      • 免疫系統疾病：體外診斷市場 - 收入，2021-2034 年
    • 其他
      • 其他：體外診斷市場 - 銷售收入，2021-2034 年

第9章 體外診斷市場收入分析－按應用領域分類

  • 基於實用性的體外診斷市場預測與分析。
    • 免洗設備
      • 一次性醫療器材：體外診斷市場－收入，2021-2034年
    • 可重複使用設備
      • 可重複使用設備：體外診斷市場 - 收入，2021-2034 年

第10章 體外診斷市場收入分析－依檢測施行地點分類

  • 按檢測地點分類的體外診斷市場預測與分析
    • 臨床檢測
      • 臨床檢測：體外診斷市場 - 銷售收入，2021-2034 年
    • 即時檢測
      • 即時檢測：體外診斷市場－收入，2021-2034年

第11章 體外診斷市場收入分析—檢體

  • 依檢體類型對體外診斷市場進行預測和分析。
    • 血清和血漿
      • 血清和血漿：體外診斷市場 - 銷售收入，2021-2034 年
    • 唾液檢體
      • 唾液檢體：體外診斷市場 - 銷售收入，2021-2034 年
    • 尿液檢體
      • 尿液檢體：體外診斷市場 - 收入，2021-2034 年
    • 其他
      • 其他：體外診斷市場 - 銷售收入，2021-2034 年

第12章 體外診斷市場收入分析－終端用戶

  • 按最終用戶分類的體外診斷市場預測和分析。
    • 醫院
      • 醫院：體外診斷市場 - 收入，2021-2034 年
    • 臨床檢查室
      • 臨床檢查室：體外診斷市場 - 銷售收入，2021-2034 年
    • 居家醫療
      • 居家照護：體外診斷市場 - 收入，2021-2034 年
    • 其他
      • 其他：體外診斷市場 - 銷售收入，2021-2034 年

第13章 體外診斷市場－區域分析

  • 北美洲
    • 產品
    • 試劑和試劑盒
    • 裝置
    • 臨床化學分析儀
    • 免疫檢測裝置
    • 尿液檢查裝置
    • 科技
    • 免疫檢測或免疫化學
    • 層析法
    • 細胞分析
    • 感測器技術
    • 分離技術
    • 分子診斷
    • 分子基因體學
    • 應用
    • 可用性
    • 測試地點
    • 檢體
    • 最終用戶
    • 美國市場
    • 加拿大市場
    • 墨西哥市場
  • 歐洲
    • 德國市場
    • 法國市場
    • 義大利市場
    • 英國市場
    • 西班牙市場
    • 其他歐洲市場
  • 亞太地區
    • 中國市場
    • 日本市場
    • 印度市場
    • 澳洲市場
    • 韓國市場
    • 亞太其他地區
  • 中東和非洲
    • 南非市場
    • 沙烏地阿拉伯市場
    • 阿拉伯聯合大公國市場
    • 其他中東和非洲市場
  • 中美洲和南美洲
    • 巴西市場
    • 阿根廷市場
    • 其他南美洲和中美洲市場

1

Product Code: TIPBT00002657

The In-Vitro Diagnostics market is anticipated to grow from US$ 112.04 Billion in 2025 to US$ 218.73 Billion by 2034; the market is expected to register a CAGR of 7.8% from 2026 to 2034. In-Vitro Diagnostics Market growth is attributed to the growing demand for non-invasive and patient-friendly diagnostic tools, growing burden of respiratory diseases such as asthma and COPD, and technological advancements and regulatory support for home monitoring.

In-vitro diagnostics (IVD) refers to medical tests conducted on biological samples such as blood, urine, or tissue outside the human body, typically in laboratories, clinics, or at the point of care. These tests are essential for detecting diseases, monitoring health conditions, and guiding clinical decision-making. IVD includes a wide range of technologies, such as immunoassays, molecular diagnostics, and clinical chemistry analyzers. It plays a critical role in early diagnosis, disease prevention, and personalized medicine. With ongoing technological advancements, IVD is becoming faster, more accurate, and increasingly accessible, supporting improved patient outcomes and more efficient healthcare systems worldwide.

The In-Vitro Diagnostics Market in North America is segmented into the US, Canada, and Mexico. The US held the largest share in North America. According to the CDC, in 2023, 76.4 % of US adults (~194 million) reported at least one chronic condition, such as heart disease, diabetes, or cancer, with multimorbidity notable across age groups, underscoring the need for frequent diagnostic monitoring and management. In 2023, diagnosed diabetes prevalence varied across counties from 4.4 % to 18.6 %, reflecting widespread metabolic disease that necessitates regular testing. According to American Cancer Society estimates, new cancer cases in 2023 and projected into 2025 remained high, reinforcing demand for oncology diagnostics. These patterns of chronic and infectious disease prevalence have increased the use of IVD technologies, as routine laboratory tests are essential for early detection, treatment planning, and disease monitoring. Recent FDA clearances and product launches, including next-generation analyzers for clinical chemistry and immunoassays in 2023, have expanded testing capabilities and speed, making diagnostics more accurate and accessible. Advances in molecular diagnostics, point-of-care testing, and personalized medicine have broadened applications of IVD, aligning with public health surveillance needs and enhancing routine clinical decision-making.

Expansion of Essential Diagnostics Access and National Diagnostic Strategies to Provide Market Opportunities in Future

One of the largest opportunities in the global IVD market is the result of the concerted efforts of governments and health organizations worldwide in increasing the availability of essential diagnostics, which play a critical role in the early detection, monitoring, and management of both infectious and non-communicable diseases . In October 2023, the World Health Organization (WHO) released its 2023 Essential Diagnostics List (EDL), adding key tests such as rapid diagnostics for hepatitis E virus and personal glucose monitoring devices for diabetes management; these updates were designed to help countries prioritize high-impact diagnostics and improve clinical outcomes across public health systems.

The WHO's global diagnostics priority initiative also links to the World Health Assembly (WHA) Resolution 76.5 in May 2023, which formally called on member states to strengthen diagnostics capacity at all health system levels a policy push that continues through 2024-2025 with implementation guidance and technical support for national inventory and prioritization of IVD products.

Further, within countries such as India, the expansion of the Free Diagnostics Service Initiative under the National Health Mission led to progressive improvement in the availability of a defined set of essential tests across public facilities by March 2024, supporting widespread routine screening for conditions such as anemia, diabetes, and infectious disease markers.

These policy-driven opportunities anchored in official diagnostics lists and national strategies provide structural momentum for IVD uptake across clinical settings where testing accessibility historically lagged.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, American Cancer Society, Statistics Canada, the National Institute of Statistics and Geography (INEGI), Robert Koch Institute (RKI), the International Diabetes Federation (IDF) are among the primary and secondary sources referred to while preparing the In-Vitro Diagnostics Market report.

Table Of Contents

1. Executive Summary

  • 1.1 Analyst Market Outlook
  • 1.2 Market Attractiveness

2. In-Vitro Diagnostic Market Landscape

  • 2.1 Overview
  • 2.2 Value Chain Analysis
  • 2.3 Supply Chain Analysis
    • 2.3.1 List of Manufacturers/Suppliers
    • 2.3.2 List of Potential Customers (Upto 50)
  • 2.4 Porter's Five Force Analysis
  • 2.5 PEST Analysis
  • 2.6 Import-Export Analysis for Key Countries (As per the nearest HS Code)
    • 2.6.1 Import-Export Analysis for Key Countries
  • 2.7 Impact of Artificial Intelligence (AI)
  • 2.8 Product or Technology Roadmap
  • 2.9 Sustainability and ESG Trends
  • 2.10 Regulatory Framework

3. Competitive Landscape

  • 3.1 Company Benchmarking by Key Players
  • 3.2 Market Share Analysis, 2025 - By Key Players
  • 3.3 Market Concentration

4. In-Vitro Diagnostic Market - Key Industry Dynamics

  • 4.1 Market Drivers
  • 4.2 Market Restraints
  • 4.3 Market Opportunities
  • 4.4 Future Trends
  • 4.5 Impact of Drivers and Restraints

5. In-Vitro Diagnostic Market - Global Market Analysis

  • 5.1 In-Vitro Diagnostic Market Revenue (US$ Million), 2021-2034
  • 5.2 In-Vitro Diagnostic Market Forecast and Analysis

6. In-Vitro Diagnostic Market Revenue Analysis - Product

  • 6.1 In-Vitro Diagnostic Market Forecasts and Analysis by Product
    • 6.1.1 Reagents and Kits
      • 6.1.1.1 Overview
      • 6.1.1.2 Reagents and Kits: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.1 Clinical Chemistry
          • 6.1.1.2.1.1 Overview
          • 6.1.1.2.1.2 Clinical Chemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.2 Immunoassay
          • 6.1.1.2.2.1 Overview
          • 6.1.1.2.2.2 Immunoassay: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.3 Hematology and Coagulation
          • 6.1.1.2.3.1 Overview
          • 6.1.1.2.3.2 Hematology and Coagulation: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.4 Molecular Diagnostics
          • 6.1.1.2.4.1 Overview
          • 6.1.1.2.4.2 Molecular Diagnostics: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.5 Microbiology and Infectious Disease
          • 6.1.1.2.5.1 Overview
          • 6.1.1.2.5.2 Microbiology and Infectious Disease: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.6 Blood Gas and Electrolyte
          • 6.1.1.2.6.1 Overview
          • 6.1.1.2.6.2 Blood Gas and Electrolyte: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.7 Flow Cytometers
          • 6.1.1.2.7.1 Overview
          • 6.1.1.2.7.2 Flow Cytometers: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.8 Urinalysis
          • 6.1.1.2.8.1 Overview
          • 6.1.1.2.8.2 Urinalysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.9 Blood Bank and Transfusion Medicine
          • 6.1.1.2.9.1 Overview
          • 6.1.1.2.9.2 Blood Bank and Transfusion Medicine: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.10 Specimen Prep and Ancillary
          • 6.1.1.2.10.1 Overview
          • 6.1.1.2.10.2 Specimen Prep and Ancillary: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 6.1.1.2.11 Specialty and Research-Grade
          • 6.1.1.2.11.1 Overview
          • 6.1.1.2.11.2 Specialty and Research-Grade: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.2 Instruments
      • 6.1.2.1 Overview
      • 6.1.2.2 Instruments: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 6.1.3 Software and Services
      • 6.1.3.1 Overview
      • 6.1.3.2 Software and Services: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

7. In-Vitro Diagnostic Market Revenue Analysis - Technology

  • 7.1 In-Vitro Diagnostic Market Forecasts and Analysis by Technology
    • 7.1.1 Immunoassay or Immunochemistry
      • 7.1.1.1 Overview
      • 7.1.1.2 Immunoassay or Immunochemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.1 Enzyme-Linked Immunosorbent Assay (ELISA)
          • 7.1.1.2.1.1 Overview
          • 7.1.1.2.1.2 Enzyme-Linked Immunosorbent Assay (ELISA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.2 Chemiluminescent Immunoassay (CLIA or ECLIA or Flash CLIA or Glow CLIA)
          • 7.1.1.2.2.1 Overview
          • 7.1.1.2.2.2 Chemiluminescent Immunoassay (CLIA or ECLIA or Flash CLIA or Glow CLIA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.3 Fluorescent Immunoassay (FIA)
          • 7.1.1.2.3.1 Overview
          • 7.1.1.2.3.2 Fluorescent Immunoassay (FIA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.4 Radioimmunoassay (RIA)
          • 7.1.1.2.4.1 Overview
          • 7.1.1.2.4.2 Radioimmunoassay (RIA): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.5 Latex Agglutination
          • 7.1.1.2.5.1 Overview
          • 7.1.1.2.5.2 Latex Agglutination: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.6 Nephelometry
          • 7.1.1.2.6.1 Overview
          • 7.1.1.2.6.2 Nephelometry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.1.2.7 Turbidimetry
          • 7.1.1.2.7.1 Overview
          • 7.1.1.2.7.2 Turbidimetry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.2 Immunochromatography
      • 7.1.2.1 Overview
      • 7.1.2.2 Immunochromatography: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.3 Cellular analysis
      • 7.1.3.1 Overview
      • 7.1.3.2 Cellular analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.3.2.1 Electrical Impedance
          • 7.1.3.2.1.1 Overview
          • 7.1.3.2.1.2 Electrical Impedance: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.3.2.2 Digital cell morphology analysis
          • 7.1.3.2.2.1 Overview
          • 7.1.3.2.2.2 Digital cell morphology analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.4 Proteomic or metabolomic
      • 7.1.4.1 Overview
      • 7.1.4.2 Proteomic or metabolomic: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.5 Sensor technology
      • 7.1.5.1 Overview
      • 7.1.5.2 Sensor technology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.5.2.1 Biochemistry
          • 7.1.5.2.1.1 Overview
          • 7.1.5.2.1.2 Biochemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.5.2.2 Electrolyte
          • 7.1.5.2.2.1 Overview
          • 7.1.5.2.2.2 Electrolyte: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.6 Miniaturized systems
      • 7.1.6.1 Overview
      • 7.1.6.2 Miniaturized systems: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.7 Multiplex technology
      • 7.1.7.1 Overview
      • 7.1.7.2 Multiplex technology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.8 Optical detection
      • 7.1.8.1 Overview
      • 7.1.8.2 Optical detection: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.9 Electrochemical analysis
      • 7.1.9.1 Overview
      • 7.1.9.2 Electrochemical analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.10 Separation technology
      • 7.1.10.1 Overview
      • 7.1.10.2 Separation technology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.1 and 50
          • 7.1.10.2.1.1 Overview
          • 7.1.10.2.1.2 and 50: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.2
          • 7.1.10.2.2.1 Overview
          • 7.1.10.2.2.2: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.10.2.3 5
          • 7.1.10.2.3.1 Overview
          • 7.1.10.2.3.2 5: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.11 Molecular Diagnosis
      • 7.1.11.1 Overview
      • 7.1.11.2 Molecular Diagnosis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.12 Analytical chemistry
      • 7.1.12.1 Overview
      • 7.1.12.2 Analytical chemistry: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.13 Molecular amplification
      • 7.1.13.1 Overview
      • 7.1.13.2 Molecular amplification: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.14 Molecular genomics
      • 7.1.14.1 Overview
      • 7.1.14.2 Molecular genomics: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.14.2.1 Sequencing (Sanger)
          • 7.1.14.2.1.1 Overview
          • 7.1.14.2.1.2 Sequencing (Sanger): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
        • 7.1.14.2.2 Next-Generation Sequencing (NGS)
          • 7.1.14.2.2.1 Overview
          • 7.1.14.2.2.2 Next-Generation Sequencing (NGS): In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.15 High-throughput molecular
      • 7.1.15.1 Overview
      • 7.1.15.2 High-throughput molecular: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 7.1.16 Genetic Analysis
      • 7.1.16.1 Overview
      • 7.1.16.2 Genetic Analysis: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

8. In-Vitro Diagnostic Market Revenue Analysis - Application

  • 8.1 In-Vitro Diagnostic Market Forecasts and Analysis by Application
    • 8.1.1 Infectious Diseases
      • 8.1.1.1 Overview
      • 8.1.1.2 Infectious Diseases: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.2 Oncology
      • 8.1.2.1 Overview
      • 8.1.2.2 Oncology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.3 Cardiology
      • 8.1.3.1 Overview
      • 8.1.3.2 Cardiology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.4 Nephrology
      • 8.1.4.1 Overview
      • 8.1.4.2 Nephrology: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.5 Diabetes
      • 8.1.5.1 Overview
      • 8.1.5.2 Diabetes: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.6 Genetic Diseases
      • 8.1.6.1 Overview
      • 8.1.6.2 Genetic Diseases: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.7 Blood Grouping and Testing
      • 8.1.7.1 Overview
      • 8.1.7.2 Blood Grouping and Testing: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.8 Allergy Diagnostics
      • 8.1.8.1 Overview
      • 8.1.8.2 Allergy Diagnostics: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.9 Gastrointestinal Diseases
      • 8.1.9.1 Overview
      • 8.1.9.2 Gastrointestinal Diseases: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.10 Immune System Disorders
      • 8.1.10.1 Overview
      • 8.1.10.2 Immune System Disorders: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 8.1.11 Others
      • 8.1.11.1 Overview
      • 8.1.11.2 Others: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

9. In-Vitro Diagnostic Market Revenue Analysis - Usability

  • 9.1 In-Vitro Diagnostic Market Forecasts and Analysis by Usability
    • 9.1.1 Disposable Devices
      • 9.1.1.1 Overview
      • 9.1.1.2 Disposable Devices: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 9.1.2 Reusable Equipment
      • 9.1.2.1 Overview
      • 9.1.2.2 Reusable Equipment: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

10. In-Vitro Diagnostic Market Revenue Analysis - Site Of Testing

  • 10.1 In-Vitro Diagnostic Market Forecasts and Analysis by Site Of Testing
    • 10.1.1 Laboratory Tests
      • 10.1.1.1 Overview
      • 10.1.1.2 Laboratory Tests: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 10.1.2 Point of Care Tests
      • 10.1.2.1 Overview
      • 10.1.2.2 Point of Care Tests: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

11. In-Vitro Diagnostic Market Revenue Analysis - Specimen

  • 11.1 In-Vitro Diagnostic Market Forecasts and Analysis by Specimen
    • 11.1.1 Blood Serum and Plasma
      • 11.1.1.1 Overview
      • 11.1.1.2 Blood Serum and Plasma: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.2 Saliva Specimens
      • 11.1.2.1 Overview
      • 11.1.2.2 Saliva Specimens: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.3 Urine Specimens
      • 11.1.3.1 Overview
      • 11.1.3.2 Urine Specimens: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 11.1.4 Others
      • 11.1.4.1 Overview
      • 11.1.4.2 Others: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

12. In-Vitro Diagnostic Market Revenue Analysis - End User

  • 12.1 In-Vitro Diagnostic Market Forecasts and Analysis by End User
    • 12.1.1 Hospitals
      • 12.1.1.1 Overview
      • 12.1.1.2 Hospitals: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.2 Clinical Laboratories
      • 12.1.2.1 Overview
      • 12.1.2.2 Clinical Laboratories: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.3 Home Care
      • 12.1.3.1 Overview
      • 12.1.3.2 Home Care: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)
    • 12.1.4 Others
      • 12.1.4.1 Overview
      • 12.1.4.2 Others: In-Vitro Diagnostic Market - Revenue, 2021-2034 (US$ Million)

13. In-Vitro Diagnostic Market - Geographical Analysis

  • 13.1 North America
    • 13.1.1 North America In-Vitro Diagnostic Market Overview
    • 13.1.2 North America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.1.3 North America: In-Vitro Diagnostic Market - By Segmentation
      • 13.1.3.1 Product
      • 13.1.3.2 Reagents And Kits
      • 13.1.3.3 Instruments
      • 13.1.3.4 Clinical Chemistry Analyzers
      • 13.1.3.5 Immunoassay Instruments
      • 13.1.3.6 Urinalysis Instruments
      • 13.1.3.7 Technology
      • 13.1.3.8 Immunoassay Or Immunochemistry
      • 13.1.3.9 Immunochromatography
      • 13.1.3.10 Cellular Analysis
      • 13.1.3.11 Sensor Technology
      • 13.1.3.12 Separation Technology
      • 13.1.3.13 Molecular Diagnosis
      • 13.1.3.14 Molecular Genomics
      • 13.1.3.15 Application
      • 13.1.3.16 Usability
      • 13.1.3.17 Site Of Testing
      • 13.1.3.18 Specimen
      • 13.1.3.19 End User
    • 13.1.4 North America: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.1.4.1 United States Market
        • 13.1.4.1.1 United States: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.1.2 United States: In-Vitro Diagnostic Market - By Segmentation
          • 13.1.4.1.2.1 Product
          • 13.1.4.1.2.2 Reagents And Kits
          • 13.1.4.1.2.3 Instruments
          • 13.1.4.1.2.4 Clinical Chemistry Analyzers
          • 13.1.4.1.2.5 Immunoassay Instruments
          • 13.1.4.1.2.6 Urinalysis Instruments
          • 13.1.4.1.2.7 Technology
          • 13.1.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.1.4.1.2.9 Immunochromatography
          • 13.1.4.1.2.10 Cellular Analysis
          • 13.1.4.1.2.11 Sensor Technology
          • 13.1.4.1.2.12 Separation Technology
          • 13.1.4.1.2.13 Molecular Diagnosis
          • 13.1.4.1.2.14 Molecular Genomics
          • 13.1.4.1.2.15 Application
          • 13.1.4.1.2.16 Usability
          • 13.1.4.1.2.17 Site Of Testing
          • 13.1.4.1.2.18 Specimen
          • 13.1.4.1.2.19 End User
      • 13.1.4.2 Canada Market
        • 13.1.4.2.1 Canada: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.2.2 Canada: In-Vitro Diagnostic Market - By Segmentation
          • 13.1.4.2.2.1 Product
          • 13.1.4.2.2.2 Reagents And Kits
          • 13.1.4.2.2.3 Instruments
          • 13.1.4.2.2.4 Clinical Chemistry Analyzers
          • 13.1.4.2.2.5 Immunoassay Instruments
          • 13.1.4.2.2.6 Urinalysis Instruments
          • 13.1.4.2.2.7 Technology
          • 13.1.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.1.4.2.2.9 Immunochromatography
          • 13.1.4.2.2.10 Cellular Analysis
          • 13.1.4.2.2.11 Sensor Technology
          • 13.1.4.2.2.12 Separation Technology
          • 13.1.4.2.2.13 Molecular Diagnosis
          • 13.1.4.2.2.14 Molecular Genomics
          • 13.1.4.2.2.15 Application
          • 13.1.4.2.2.16 Usability
          • 13.1.4.2.2.17 Site Of Testing
          • 13.1.4.2.2.18 Specimen
          • 13.1.4.2.2.19 End User
      • 13.1.4.3 Mexico Market
        • 13.1.4.3.1 Mexico: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.1.4.3.2 Mexico: In-Vitro Diagnostic Market - By Segmentation
          • 13.1.4.3.2.1 Product
          • 13.1.4.3.2.2 Reagents And Kits
          • 13.1.4.3.2.3 Instruments
          • 13.1.4.3.2.4 Clinical Chemistry Analyzers
          • 13.1.4.3.2.5 Immunoassay Instruments
          • 13.1.4.3.2.6 Urinalysis Instruments
          • 13.1.4.3.2.7 Technology
          • 13.1.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.1.4.3.2.9 Immunochromatography
          • 13.1.4.3.2.10 Cellular Analysis
          • 13.1.4.3.2.11 Sensor Technology
          • 13.1.4.3.2.12 Separation Technology
          • 13.1.4.3.2.13 Molecular Diagnosis
          • 13.1.4.3.2.14 Molecular Genomics
          • 13.1.4.3.2.15 Application
          • 13.1.4.3.2.16 Usability
          • 13.1.4.3.2.17 Site Of Testing
          • 13.1.4.3.2.18 Specimen
          • 13.1.4.3.2.19 End User
  • 13.2 Europe
    • 13.2.1 Europe In-Vitro Diagnostic Market Overview
    • 13.2.2 Europe: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.2.3 Europe: In-Vitro Diagnostic Market - By Segmentation
      • 13.2.3.1 Product
      • 13.2.3.2 Reagents And Kits
      • 13.2.3.3 Instruments
      • 13.2.3.4 Clinical Chemistry Analyzers
      • 13.2.3.5 Immunoassay Instruments
      • 13.2.3.6 Urinalysis Instruments
      • 13.2.3.7 Technology
      • 13.2.3.8 Immunoassay Or Immunochemistry
      • 13.2.3.9 Immunochromatography
      • 13.2.3.10 Cellular Analysis
      • 13.2.3.11 Sensor Technology
      • 13.2.3.12 Separation Technology
      • 13.2.3.13 Molecular Diagnosis
      • 13.2.3.14 Molecular Genomics
      • 13.2.3.15 Application
      • 13.2.3.16 Usability
      • 13.2.3.17 Site Of Testing
      • 13.2.3.18 Specimen
      • 13.2.3.19 End User
    • 13.2.4 Europe: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.2.4.1 Germany Market
        • 13.2.4.1.1 Germany: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.1.2 Germany: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.1.2.1 Product
          • 13.2.4.1.2.2 Reagents And Kits
          • 13.2.4.1.2.3 Instruments
          • 13.2.4.1.2.4 Clinical Chemistry Analyzers
          • 13.2.4.1.2.5 Immunoassay Instruments
          • 13.2.4.1.2.6 Urinalysis Instruments
          • 13.2.4.1.2.7 Technology
          • 13.2.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.1.2.9 Immunochromatography
          • 13.2.4.1.2.10 Cellular Analysis
          • 13.2.4.1.2.11 Sensor Technology
          • 13.2.4.1.2.12 Separation Technology
          • 13.2.4.1.2.13 Molecular Diagnosis
          • 13.2.4.1.2.14 Molecular Genomics
          • 13.2.4.1.2.15 Application
          • 13.2.4.1.2.16 Usability
          • 13.2.4.1.2.17 Site Of Testing
          • 13.2.4.1.2.18 Specimen
          • 13.2.4.1.2.19 End User
      • 13.2.4.2 France Market
        • 13.2.4.2.1 France: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.2.2 France: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.2.2.1 Product
          • 13.2.4.2.2.2 Reagents And Kits
          • 13.2.4.2.2.3 Instruments
          • 13.2.4.2.2.4 Clinical Chemistry Analyzers
          • 13.2.4.2.2.5 Immunoassay Instruments
          • 13.2.4.2.2.6 Urinalysis Instruments
          • 13.2.4.2.2.7 Technology
          • 13.2.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.2.2.9 Immunochromatography
          • 13.2.4.2.2.10 Cellular Analysis
          • 13.2.4.2.2.11 Sensor Technology
          • 13.2.4.2.2.12 Separation Technology
          • 13.2.4.2.2.13 Molecular Diagnosis
          • 13.2.4.2.2.14 Molecular Genomics
          • 13.2.4.2.2.15 Application
          • 13.2.4.2.2.16 Usability
          • 13.2.4.2.2.17 Site Of Testing
          • 13.2.4.2.2.18 Specimen
          • 13.2.4.2.2.19 End User
      • 13.2.4.3 Italy Market
        • 13.2.4.3.1 Italy: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.3.2 Italy: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.3.2.1 Product
          • 13.2.4.3.2.2 Reagents And Kits
          • 13.2.4.3.2.3 Instruments
          • 13.2.4.3.2.4 Clinical Chemistry Analyzers
          • 13.2.4.3.2.5 Immunoassay Instruments
          • 13.2.4.3.2.6 Urinalysis Instruments
          • 13.2.4.3.2.7 Technology
          • 13.2.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.3.2.9 Immunochromatography
          • 13.2.4.3.2.10 Cellular Analysis
          • 13.2.4.3.2.11 Sensor Technology
          • 13.2.4.3.2.12 Separation Technology
          • 13.2.4.3.2.13 Molecular Diagnosis
          • 13.2.4.3.2.14 Molecular Genomics
          • 13.2.4.3.2.15 Application
          • 13.2.4.3.2.16 Usability
          • 13.2.4.3.2.17 Site Of Testing
          • 13.2.4.3.2.18 Specimen
          • 13.2.4.3.2.19 End User
      • 13.2.4.4 United Kingdom Market
        • 13.2.4.4.1 United Kingdom: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.4.2 United Kingdom: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.4.2.1 Product
          • 13.2.4.4.2.2 Reagents And Kits
          • 13.2.4.4.2.3 Instruments
          • 13.2.4.4.2.4 Clinical Chemistry Analyzers
          • 13.2.4.4.2.5 Immunoassay Instruments
          • 13.2.4.4.2.6 Urinalysis Instruments
          • 13.2.4.4.2.7 Technology
          • 13.2.4.4.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.4.2.9 Immunochromatography
          • 13.2.4.4.2.10 Cellular Analysis
          • 13.2.4.4.2.11 Sensor Technology
          • 13.2.4.4.2.12 Separation Technology
          • 13.2.4.4.2.13 Molecular Diagnosis
          • 13.2.4.4.2.14 Molecular Genomics
          • 13.2.4.4.2.15 Application
          • 13.2.4.4.2.16 Usability
          • 13.2.4.4.2.17 Site Of Testing
          • 13.2.4.4.2.18 Specimen
          • 13.2.4.4.2.19 End User
      • 13.2.4.5 Spain Market
        • 13.2.4.5.1 Spain: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.5.2 Spain: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.5.2.1 Product
          • 13.2.4.5.2.2 Reagents And Kits
          • 13.2.4.5.2.3 Instruments
          • 13.2.4.5.2.4 Clinical Chemistry Analyzers
          • 13.2.4.5.2.5 Immunoassay Instruments
          • 13.2.4.5.2.6 Urinalysis Instruments
          • 13.2.4.5.2.7 Technology
          • 13.2.4.5.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.5.2.9 Immunochromatography
          • 13.2.4.5.2.10 Cellular Analysis
          • 13.2.4.5.2.11 Sensor Technology
          • 13.2.4.5.2.12 Separation Technology
          • 13.2.4.5.2.13 Molecular Diagnosis
          • 13.2.4.5.2.14 Molecular Genomics
          • 13.2.4.5.2.15 Application
          • 13.2.4.5.2.16 Usability
          • 13.2.4.5.2.17 Site Of Testing
          • 13.2.4.5.2.18 Specimen
          • 13.2.4.5.2.19 End User
      • 13.2.4.6 Rest of Europe Market
        • 13.2.4.6.1 Rest of Europe: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.2.4.6.2 Rest of Europe: In-Vitro Diagnostic Market - By Segmentation
          • 13.2.4.6.2.1 Product
          • 13.2.4.6.2.2 Reagents And Kits
          • 13.2.4.6.2.3 Instruments
          • 13.2.4.6.2.4 Clinical Chemistry Analyzers
          • 13.2.4.6.2.5 Immunoassay Instruments
          • 13.2.4.6.2.6 Urinalysis Instruments
          • 13.2.4.6.2.7 Technology
          • 13.2.4.6.2.8 Immunoassay Or Immunochemistry
          • 13.2.4.6.2.9 Immunochromatography
          • 13.2.4.6.2.10 Cellular Analysis
          • 13.2.4.6.2.11 Sensor Technology
          • 13.2.4.6.2.12 Separation Technology
          • 13.2.4.6.2.13 Molecular Diagnosis
          • 13.2.4.6.2.14 Molecular Genomics
          • 13.2.4.6.2.15 Application
          • 13.2.4.6.2.16 Usability
          • 13.2.4.6.2.17 Site Of Testing
          • 13.2.4.6.2.18 Specimen
          • 13.2.4.6.2.19 End User
  • 13.3 Asia Pacific
    • 13.3.1 Asia Pacific In-Vitro Diagnostic Market Overview
    • 13.3.2 Asia Pacific: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.3.3 Asia Pacific: In-Vitro Diagnostic Market - By Segmentation
      • 13.3.3.1 Product
      • 13.3.3.2 Reagents And Kits
      • 13.3.3.3 Instruments
      • 13.3.3.4 Clinical Chemistry Analyzers
      • 13.3.3.5 Immunoassay Instruments
      • 13.3.3.6 Urinalysis Instruments
      • 13.3.3.7 Technology
      • 13.3.3.8 Immunoassay Or Immunochemistry
      • 13.3.3.9 Immunochromatography
      • 13.3.3.10 Cellular Analysis
      • 13.3.3.11 Sensor Technology
      • 13.3.3.12 Separation Technology
      • 13.3.3.13 Molecular Diagnosis
      • 13.3.3.14 Molecular Genomics
      • 13.3.3.15 Application
      • 13.3.3.16 Usability
      • 13.3.3.17 Site Of Testing
      • 13.3.3.18 Specimen
      • 13.3.3.19 End User
    • 13.3.4 Asia Pacific: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.3.4.1 China Market
        • 13.3.4.1.1 China: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.1.2 China: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.1.2.1 Product
          • 13.3.4.1.2.2 Reagents And Kits
          • 13.3.4.1.2.3 Instruments
          • 13.3.4.1.2.4 Clinical Chemistry Analyzers
          • 13.3.4.1.2.5 Immunoassay Instruments
          • 13.3.4.1.2.6 Urinalysis Instruments
          • 13.3.4.1.2.7 Technology
          • 13.3.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.1.2.9 Immunochromatography
          • 13.3.4.1.2.10 Cellular Analysis
          • 13.3.4.1.2.11 Sensor Technology
          • 13.3.4.1.2.12 Separation Technology
          • 13.3.4.1.2.13 Molecular Diagnosis
          • 13.3.4.1.2.14 Molecular Genomics
          • 13.3.4.1.2.15 Application
          • 13.3.4.1.2.16 Usability
          • 13.3.4.1.2.17 Site Of Testing
          • 13.3.4.1.2.18 Specimen
          • 13.3.4.1.2.19 End User
      • 13.3.4.2 Japan Market
        • 13.3.4.2.1 Japan: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.2.2 Japan: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.2.2.1 Product
          • 13.3.4.2.2.2 Reagents And Kits
          • 13.3.4.2.2.3 Instruments
          • 13.3.4.2.2.4 Clinical Chemistry Analyzers
          • 13.3.4.2.2.5 Immunoassay Instruments
          • 13.3.4.2.2.6 Urinalysis Instruments
          • 13.3.4.2.2.7 Technology
          • 13.3.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.2.2.9 Immunochromatography
          • 13.3.4.2.2.10 Cellular Analysis
          • 13.3.4.2.2.11 Sensor Technology
          • 13.3.4.2.2.12 Separation Technology
          • 13.3.4.2.2.13 Molecular Diagnosis
          • 13.3.4.2.2.14 Molecular Genomics
          • 13.3.4.2.2.15 Application
          • 13.3.4.2.2.16 Usability
          • 13.3.4.2.2.17 Site Of Testing
          • 13.3.4.2.2.18 Specimen
          • 13.3.4.2.2.19 End User
      • 13.3.4.3 India Market
        • 13.3.4.3.1 India: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.3.2 India: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.3.2.1 Product
          • 13.3.4.3.2.2 Reagents And Kits
          • 13.3.4.3.2.3 Instruments
          • 13.3.4.3.2.4 Clinical Chemistry Analyzers
          • 13.3.4.3.2.5 Immunoassay Instruments
          • 13.3.4.3.2.6 Urinalysis Instruments
          • 13.3.4.3.2.7 Technology
          • 13.3.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.3.2.9 Immunochromatography
          • 13.3.4.3.2.10 Cellular Analysis
          • 13.3.4.3.2.11 Sensor Technology
          • 13.3.4.3.2.12 Separation Technology
          • 13.3.4.3.2.13 Molecular Diagnosis
          • 13.3.4.3.2.14 Molecular Genomics
          • 13.3.4.3.2.15 Application
          • 13.3.4.3.2.16 Usability
          • 13.3.4.3.2.17 Site Of Testing
          • 13.3.4.3.2.18 Specimen
          • 13.3.4.3.2.19 End User
      • 13.3.4.4 Australia Market
        • 13.3.4.4.1 Australia: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.4.2 Australia: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.4.2.1 Product
          • 13.3.4.4.2.2 Reagents And Kits
          • 13.3.4.4.2.3 Instruments
          • 13.3.4.4.2.4 Clinical Chemistry Analyzers
          • 13.3.4.4.2.5 Immunoassay Instruments
          • 13.3.4.4.2.6 Urinalysis Instruments
          • 13.3.4.4.2.7 Technology
          • 13.3.4.4.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.4.2.9 Immunochromatography
          • 13.3.4.4.2.10 Cellular Analysis
          • 13.3.4.4.2.11 Sensor Technology
          • 13.3.4.4.2.12 Separation Technology
          • 13.3.4.4.2.13 Molecular Diagnosis
          • 13.3.4.4.2.14 Molecular Genomics
          • 13.3.4.4.2.15 Application
          • 13.3.4.4.2.16 Usability
          • 13.3.4.4.2.17 Site Of Testing
          • 13.3.4.4.2.18 Specimen
          • 13.3.4.4.2.19 End User
      • 13.3.4.5 South Korea Market
        • 13.3.4.5.1 South Korea: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.5.2 South Korea: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.5.2.1 Product
          • 13.3.4.5.2.2 Reagents And Kits
          • 13.3.4.5.2.3 Instruments
          • 13.3.4.5.2.4 Clinical Chemistry Analyzers
          • 13.3.4.5.2.5 Immunoassay Instruments
          • 13.3.4.5.2.6 Urinalysis Instruments
          • 13.3.4.5.2.7 Technology
          • 13.3.4.5.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.5.2.9 Immunochromatography
          • 13.3.4.5.2.10 Cellular Analysis
          • 13.3.4.5.2.11 Sensor Technology
          • 13.3.4.5.2.12 Separation Technology
          • 13.3.4.5.2.13 Molecular Diagnosis
          • 13.3.4.5.2.14 Molecular Genomics
          • 13.3.4.5.2.15 Application
          • 13.3.4.5.2.16 Usability
          • 13.3.4.5.2.17 Site Of Testing
          • 13.3.4.5.2.18 Specimen
          • 13.3.4.5.2.19 End User
      • 13.3.4.6 Rest of Asia Pacific Market
        • 13.3.4.6.1 Rest of Asia Pacific: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.3.4.6.2 Rest of Asia Pacific: In-Vitro Diagnostic Market - By Segmentation
          • 13.3.4.6.2.1 Product
          • 13.3.4.6.2.2 Reagents And Kits
          • 13.3.4.6.2.3 Instruments
          • 13.3.4.6.2.4 Clinical Chemistry Analyzers
          • 13.3.4.6.2.5 Immunoassay Instruments
          • 13.3.4.6.2.6 Urinalysis Instruments
          • 13.3.4.6.2.7 Technology
          • 13.3.4.6.2.8 Immunoassay Or Immunochemistry
          • 13.3.4.6.2.9 Immunochromatography
          • 13.3.4.6.2.10 Cellular Analysis
          • 13.3.4.6.2.11 Sensor Technology
          • 13.3.4.6.2.12 Separation Technology
          • 13.3.4.6.2.13 Molecular Diagnosis
          • 13.3.4.6.2.14 Molecular Genomics
          • 13.3.4.6.2.15 Application
          • 13.3.4.6.2.16 Usability
          • 13.3.4.6.2.17 Site Of Testing
          • 13.3.4.6.2.18 Specimen
          • 13.3.4.6.2.19 End User
  • 13.4 Middle East and Africa
    • 13.4.1 Middle East and Africa In-Vitro Diagnostic Market Overview
    • 13.4.2 Middle East and Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.4.3 Middle East and Africa: In-Vitro Diagnostic Market - By Segmentation
      • 13.4.3.1 Product
      • 13.4.3.2 Reagents And Kits
      • 13.4.3.3 Instruments
      • 13.4.3.4 Clinical Chemistry Analyzers
      • 13.4.3.5 Immunoassay Instruments
      • 13.4.3.6 Urinalysis Instruments
      • 13.4.3.7 Technology
      • 13.4.3.8 Immunoassay Or Immunochemistry
      • 13.4.3.9 Immunochromatography
      • 13.4.3.10 Cellular Analysis
      • 13.4.3.11 Sensor Technology
      • 13.4.3.12 Separation Technology
      • 13.4.3.13 Molecular Diagnosis
      • 13.4.3.14 Molecular Genomics
      • 13.4.3.15 Application
      • 13.4.3.16 Usability
      • 13.4.3.17 Site Of Testing
      • 13.4.3.18 Specimen
      • 13.4.3.19 End User
    • 13.4.4 Middle East and Africa: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.4.4.1 South Africa Market
        • 13.4.4.1.1 South Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.1.2 South Africa: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.1.2.1 Product
          • 13.4.4.1.2.2 Reagents And Kits
          • 13.4.4.1.2.3 Instruments
          • 13.4.4.1.2.4 Clinical Chemistry Analyzers
          • 13.4.4.1.2.5 Immunoassay Instruments
          • 13.4.4.1.2.6 Urinalysis Instruments
          • 13.4.4.1.2.7 Technology
          • 13.4.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.1.2.9 Immunochromatography
          • 13.4.4.1.2.10 Cellular Analysis
          • 13.4.4.1.2.11 Sensor Technology
          • 13.4.4.1.2.12 Separation Technology
          • 13.4.4.1.2.13 Molecular Diagnosis
          • 13.4.4.1.2.14 Molecular Genomics
          • 13.4.4.1.2.15 Application
          • 13.4.4.1.2.16 Usability
          • 13.4.4.1.2.17 Site Of Testing
          • 13.4.4.1.2.18 Specimen
          • 13.4.4.1.2.19 End User
      • 13.4.4.2 Saudi Arabia Market
        • 13.4.4.2.1 Saudi Arabia: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.2.2 Saudi Arabia: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.2.2.1 Product
          • 13.4.4.2.2.2 Reagents And Kits
          • 13.4.4.2.2.3 Instruments
          • 13.4.4.2.2.4 Clinical Chemistry Analyzers
          • 13.4.4.2.2.5 Immunoassay Instruments
          • 13.4.4.2.2.6 Urinalysis Instruments
          • 13.4.4.2.2.7 Technology
          • 13.4.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.2.2.9 Immunochromatography
          • 13.4.4.2.2.10 Cellular Analysis
          • 13.4.4.2.2.11 Sensor Technology
          • 13.4.4.2.2.12 Separation Technology
          • 13.4.4.2.2.13 Molecular Diagnosis
          • 13.4.4.2.2.14 Molecular Genomics
          • 13.4.4.2.2.15 Application
          • 13.4.4.2.2.16 Usability
          • 13.4.4.2.2.17 Site Of Testing
          • 13.4.4.2.2.18 Specimen
          • 13.4.4.2.2.19 End User
      • 13.4.4.3 United Arab Emirates Market
        • 13.4.4.3.1 United Arab Emirates: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.3.2 United Arab Emirates: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.3.2.1 Product
          • 13.4.4.3.2.2 Reagents And Kits
          • 13.4.4.3.2.3 Instruments
          • 13.4.4.3.2.4 Clinical Chemistry Analyzers
          • 13.4.4.3.2.5 Immunoassay Instruments
          • 13.4.4.3.2.6 Urinalysis Instruments
          • 13.4.4.3.2.7 Technology
          • 13.4.4.3.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.3.2.9 Immunochromatography
          • 13.4.4.3.2.10 Cellular Analysis
          • 13.4.4.3.2.11 Sensor Technology
          • 13.4.4.3.2.12 Separation Technology
          • 13.4.4.3.2.13 Molecular Diagnosis
          • 13.4.4.3.2.14 Molecular Genomics
          • 13.4.4.3.2.15 Application
          • 13.4.4.3.2.16 Usability
          • 13.4.4.3.2.17 Site Of Testing
          • 13.4.4.3.2.18 Specimen
          • 13.4.4.3.2.19 End User
      • 13.4.4.4 Rest of Middle East and Africa Market
        • 13.4.4.4.1 Rest of Middle East and Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.4.4.4.2 Rest of Middle East and Africa: In-Vitro Diagnostic Market - By Segmentation
          • 13.4.4.4.2.1 Product
          • 13.4.4.4.2.2 Reagents And Kits
          • 13.4.4.4.2.3 Instruments
          • 13.4.4.4.2.4 Clinical Chemistry Analyzers
          • 13.4.4.4.2.5 Immunoassay Instruments
          • 13.4.4.4.2.6 Urinalysis Instruments
          • 13.4.4.4.2.7 Technology
          • 13.4.4.4.2.8 Immunoassay Or Immunochemistry
          • 13.4.4.4.2.9 Immunochromatography
          • 13.4.4.4.2.10 Cellular Analysis
          • 13.4.4.4.2.11 Sensor Technology
          • 13.4.4.4.2.12 Separation Technology
          • 13.4.4.4.2.13 Molecular Diagnosis
          • 13.4.4.4.2.14 Molecular Genomics
          • 13.4.4.4.2.15 Application
          • 13.4.4.4.2.16 Usability
          • 13.4.4.4.2.17 Site Of Testing
          • 13.4.4.4.2.18 Specimen
          • 13.4.4.4.2.19 End User
  • 13.5 South and Central America
    • 13.5.1 South and Central America In-Vitro Diagnostic Market Overview
    • 13.5.2 South and Central America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
    • 13.5.3 South and Central America: In-Vitro Diagnostic Market - By Segmentation
      • 13.5.3.1 Product
      • 13.5.3.2 Reagents And Kits
      • 13.5.3.3 Instruments
      • 13.5.3.4 Clinical Chemistry Analyzers
      • 13.5.3.5 Immunoassay Instruments
      • 13.5.3.6 Urinalysis Instruments
      • 13.5.3.7 Technology
      • 13.5.3.8 Immunoassay Or Immunochemistry
      • 13.5.3.9 Immunochromatography
      • 13.5.3.10 Cellular Analysis
      • 13.5.3.11 Sensor Technology
      • 13.5.3.12 Separation Technology
      • 13.5.3.13 Molecular Diagnosis
      • 13.5.3.14 Molecular Genomics
      • 13.5.3.15 Application
      • 13.5.3.16 Usability
      • 13.5.3.17 Site Of Testing
      • 13.5.3.18 Specimen
      • 13.5.3.19 End User
    • 13.5.4 South and Central America: In-Vitro Diagnostic Market Breakdown by Countries
      • 13.5.4.1 Brazil Market
        • 13.5.4.1.1 Brazil: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.1.2 Brazil: In-Vitro Diagnostic Market - By Segmentation
          • 13.5.4.1.2.1 Product
          • 13.5.4.1.2.2 Reagents And Kits
          • 13.5.4.1.2.3 Instruments
          • 13.5.4.1.2.4 Clinical Chemistry Analyzers
          • 13.5.4.1.2.5 Immunoassay Instruments
          • 13.5.4.1.2.6 Urinalysis Instruments
          • 13.5.4.1.2.7 Technology
          • 13.5.4.1.2.8 Immunoassay Or Immunochemistry
          • 13.5.4.1.2.9 Immunochromatography
          • 13.5.4.1.2.10 Cellular Analysis
          • 13.5.4.1.2.11 Sensor Technology
          • 13.5.4.1.2.12 Separation Technology
          • 13.5.4.1.2.13 Molecular Diagnosis
          • 13.5.4.1.2.14 Molecular Genomics
          • 13.5.4.1.2.15 Application
          • 13.5.4.1.2.16 Usability
          • 13.5.4.1.2.17 Site Of Testing
          • 13.5.4.1.2.18 Specimen
          • 13.5.4.1.2.19 End User
      • 13.5.4.2 Argentina Market
        • 13.5.4.2.1 Argentina: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.2.2 Argentina: In-Vitro Diagnostic Market - By Segmentation
          • 13.5.4.2.2.1 Product
          • 13.5.4.2.2.2 Reagents And Kits
          • 13.5.4.2.2.3 Instruments
          • 13.5.4.2.2.4 Clinical Chemistry Analyzers
          • 13.5.4.2.2.5 Immunoassay Instruments
          • 13.5.4.2.2.6 Urinalysis Instruments
          • 13.5.4.2.2.7 Technology
          • 13.5.4.2.2.8 Immunoassay Or Immunochemistry
          • 13.5.4.2.2.9 Immunochromatography
          • 13.5.4.2.2.10 Cellular Analysis
          • 13.5.4.2.2.11 Sensor Technology
          • 13.5.4.2.2.12 Separation Technology
          • 13.5.4.2.2.13 Molecular Diagnosis
          • 13.5.4.2.2.14 Molecular Genomics
          • 13.5.4.2.2.15 Application
          • 13.5.4.2.2.16 Usability
          • 13.5.4.2.2.17 Site Of Testing
          • 13.5.4.2.2.18 Specimen
          • 13.5.4.2.2.19 End User
      • 13.5.4.3 Rest of South and Central America Market
        • 13.5.4.3.1 Rest of South and Central America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
        • 13.5.4.3.2 Rest of South and Central America: In-Vitro Diagnostic Market - By Segmentation
          • 13.5.4.3.2.1 Product
          • 13.5.4.3.2.2 Reagents And Kits
          • 13.5.4.3.2.3 Instruments
          • 13.5.4.3.2.4 Clinical Chemistry Analyzers
          • 13.5.4.3.2.5 Immunoassay Instruments
          • 13.5.4.3.2.6 Urinalysis Instruments
          • 13.5.4.3.2.7 Technology
          • 13.5.4.3.2.8 Immunoassay Or Immunochemistry

1

List Of Tables

  • Table 1. In-Vitro Diagnostic Market Segmentation.
  • Table 2. List of Regulatory Bodies and Organizations
  • Table 3. Ease of Doing Business: Key Country Rankings
  • Table 4. Market Share Analysis, 2025 - By Key Players
  • Table 5. In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million)
  • Table 6. In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million)
  • Table 7. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 8. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 9. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 10. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 11. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 12. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 13. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 14. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 15. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 16. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 17. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 18. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 19. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 20. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 21. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 22. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 23. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 24. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 25. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 26. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 27. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 28. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 29. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 30. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 31. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 32. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 33. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 34. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 35. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 36. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 37. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 38. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 39. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 40. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 41. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 42. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 43. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 44. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 45. North America: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 46. North America: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 47. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 48. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 49. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 50. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 51. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 52. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 53. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 54. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 55. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 56. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 57. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 58. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 59. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 60. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 61. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 62. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 63. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 64. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 65. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 66. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 67. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 68. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 69. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 70. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 71. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 72. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 73. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 74. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 75. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 76. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 77. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 78. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 79. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 80. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 81. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 82. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 83. United States: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 84. United States: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 85. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 86. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 87. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 88. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 89. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 90. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 91. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 92. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 93. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 94. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 95. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 96. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 97. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 98. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 99. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 100. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 101. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 102. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 103. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 104. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 105. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 106. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 107. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 108. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 109. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 110. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 111. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 112. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 113. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 114. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 115. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 116. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 117. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 118. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 119. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 120. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 121. Canada: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 122. Canada: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 123. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 124. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 125. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 126. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 127. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 128. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 129. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 130. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 131. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 132. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 133. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 134. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 135. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 136. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 137. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 138. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 139. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 140. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 141. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 142. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 143. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 144. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 145. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 146. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 147. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 148. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 149. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 150. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 151. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 152. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 153. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 154. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 155. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 156. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 157. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 158. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 159. Mexico: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 160. Mexico: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 161. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 162. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 163. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 164. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 165. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 166. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 167. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 168. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 169. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 170. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 171. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 172. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 173. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 174. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 175. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 176. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 177. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 178. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 179. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 180. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 181. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 182. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 183. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 184. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 185. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 186. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 187. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 188. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 189. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 190. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 191. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 192. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 193. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 194. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 195. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 196. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 197. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 198. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 199. Europe: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Country
  • Table 200. Europe: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Country
  • Table 201. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 202. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 203. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 204. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 205. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 206. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 207. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 208. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 209. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 210. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 211. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 212. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 213. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 214. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 215. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 216. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 217. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 218. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 219. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 220. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 221. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 222. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 223. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 224. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 225. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 226. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 227. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 228. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 229. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 230. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 231. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 232. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 233. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 234. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 235. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 236. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 237. Germany: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 238. Germany: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 239. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 240. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 241. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 242. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 243. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 244. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 245. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 246. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 247. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 248. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 249. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 250. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 251. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 252. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 253. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 254. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 255. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 256. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 257. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 258. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 259. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 260. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 261. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 262. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 263. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 264. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Diagnosis
  • Table 265. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Genomics
  • Table 266. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Molecular Genomics
  • Table 267. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Application
  • Table 268. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Application
  • Table 269. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Usability
  • Table 270. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Usability
  • Table 271. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Site Of Testing
  • Table 272. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Site Of Testing
  • Table 273. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Specimen
  • Table 274. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Specimen
  • Table 275. France: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by End User
  • Table 276. France: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by End User
  • Table 277. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Product
  • Table 278. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Product
  • Table 279. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Reagents And Kits
  • Table 280. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Reagents And Kits
  • Table 281. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Instruments
  • Table 282. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Instruments
  • Table 283. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 284. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Clinical Chemistry Analyzers
  • Table 285. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Instruments
  • Table 286. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Instruments
  • Table 287. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Urinalysis Instruments
  • Table 288. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Urinalysis Instruments
  • Table 289. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Technology
  • Table 290. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Technology
  • Table 291. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 292. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunoassay Or Immunochemistry
  • Table 293. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Immunochromatography
  • Table 294. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Immunochromatography
  • Table 295. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Cellular Analysis
  • Table 296. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Cellular Analysis
  • Table 297. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Sensor Technology
  • Table 298. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Sensor Technology
  • Table 299. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Separation Technology
  • Table 300. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) - by Separation Technology
  • Table 301. Italy: In-Vitro Diagnostic Market - Revenue, 2021-2025 (US$ Million) - by Molecular Diagnosis
  • Table 302. Italy: In-Vitro Diagnostic Market - Revenue Forecast, 2026-2034 (US$ Million) -

List Of Figures

  • Figure 1. In-Vitro Diagnostic Market - Value Chain Analysis
  • Figure 2. Porter's Five Forces Analysis
  • Figure 3. Pest Analysis
  • Figure 4. In-Vitro Diagnostic Market - Key Industry Dynamics
  • Figure 5. Impact Analysis of Drivers and Restraints
  • Figure 6. In-Vitro Diagnostic Market Revenue (US$ Million), 2021-2034
  • Figure 7. In-Vitro Diagnostic Market Share (%) - by Product (2025 and 2034)
  • Figure 8. Reagents and Kits: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 9. Clinical Chemistry: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 10. Immunoassay: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 11. Hematology and Coagulation: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 12. Molecular Diagnostics: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 13. Microbiology and Infectious Disease: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 14. Blood Gas and Electrolyte: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 15. Flow Cytometers: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 16. Urinalysis: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 17. Blood Bank and Transfusion Medicine: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 18. Specimen Prep and Ancillary: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 19. Specialty and Research-Grade: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 20. Instruments: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 21. Software and Services: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 22. In-Vitro Diagnostic Market Share (%) - by Technology (2025 and 2034)
  • Figure 23. Immunoassay or Immunochemistry: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 24. Enzyme-Linked Immunosorbent Assay (ELISA): In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 25. Chemiluminescent Immunoassay (CLIA or ECLIA or Flash CLIA or Glow CLIA): In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 26. Fluorescent Immunoassay (FIA): In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 27. Radioimmunoassay (RIA): In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 28. Latex Agglutination: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 29. Nephelometry: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 30. Turbidimetry: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 31. Immunochromatography: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 32. Cellular analysis: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 33. Electrical Impedance: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 34. Digital cell morphology analysis: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 35. Proteomic or metabolomic: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 36. Sensor technology: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 37. Biochemistry: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 38. Electrolyte: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 39. Miniaturized systems: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 40. Multiplex technology: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 41. Optical detection: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 42. Electrochemical analysis: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 43. Separation technology: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 44. and 50: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 45.: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 46. 5: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 47. Molecular Diagnosis: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 48. Analytical chemistry: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 49. Molecular amplification: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 50. Molecular genomics: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 51. Sequencing (Sanger): In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 52. Next-Generation Sequencing (NGS): In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 53. High-throughput molecular: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 54. Genetic Analysis: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 55. In-Vitro Diagnostic Market Share (%) - by Application (2025 and 2034)
  • Figure 56. Infectious Diseases: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 57. Oncology: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 58. Cardiology: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 59. Nephrology: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 60. Diabetes: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 61. Genetic Diseases: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 62. Blood Grouping and Testing: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 63. Allergy Diagnostics: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 64. Gastrointestinal Diseases: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 65. Immune System Disorders: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 66. Others: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 67. In-Vitro Diagnostic Market Share (%) - by Usability (2025 and 2034)
  • Figure 68. Disposable Devices: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 69. Reusable Equipment: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 70. In-Vitro Diagnostic Market Share (%) - by Site Of Testing (2025 and 2034)
  • Figure 71. Laboratory Tests: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 72. Point of Care Tests: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 73. In-Vitro Diagnostic Market Share (%) - by Specimen (2025 and 2034)
  • Figure 74. Blood Serum and Plasma: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 75. Saliva Specimens: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 76. Urine Specimens: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 77. Others: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 78. In-Vitro Diagnostic Market Share (%) - by End User (2025 and 2034)
  • Figure 79. Hospitals: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 80. Clinical Laboratories: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 81. Home Care: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 82. Others: In-Vitro Diagnostic Market - Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 83. In-Vitro Diagnostic Market Breakdown by Geography, 2025 and 2034
  • Figure 84. North America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 85. North America: In-Vitro Diagnostic Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 86. United States: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 87. Canada: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 88. Mexico: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 89. Europe: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 90. Europe: In-Vitro Diagnostic Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 91. Germany: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 92. France: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 93. Italy: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 94. United Kingdom: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 95. Spain: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 96. Rest of Europe: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 97. Asia Pacific: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 98. Asia Pacific: In-Vitro Diagnostic Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 99. China: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 100. Japan: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 101. India: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 102. Australia: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 103. South Korea: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 104. Rest of Asia Pacific: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 105. Middle East and Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 106. Middle East and Africa: In-Vitro Diagnostic Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 107. South Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 108. Saudi Arabia: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 109. United Arab Emirates: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 110. Rest of Middle East and Africa: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 111. South and Central America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 112. South and Central America: In-Vitro Diagnostic Market Breakdown by Key Countries, 2025 and 2034 (%)
  • Figure 113. Brazil: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 114. Argentina: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 115. Rest of South and Central America: In-Vitro Diagnostic Market Revenue and Forecasts, 2021-2034 (US$ Million)
  • Figure 116. Bottom-Up Approach and Top-Down Approach